New findings could help scientists develop treatments for the condition known as ITP.
therapy
OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.
International study reveals 24 new genes associated with lupus
These findings will help scientists understand how to better diagnose and treat the disease.
OMRF researcher tests new approach for treating deadly blood infection
Lupu’s findings were published in the Proceedings of the National Academy of Sciences.
Q BioMed Inc. finalizes license agreement with OMRF, RGCB
QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
Blood test identifies people at high risk for lupus
New research will help physicians better identify blood relatives of lupus patients at risk for developing the disease.
